We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Precursive's web and mobile application helps customers to manage their resources more efficiently. Precursive does this by helping employers to schedule and plan all of their employees who are working on client chargable work.
days to go: Expired investment: £250,000
Lone Design Club is a new retail concept which runs innovative and disruptive pop-up stores and gives voice to small independent brands in creating unique and sustainable fashion. The platform's founder has validated and supported more than 200 designers in 16 stores. The company has multiple revenue streams: commission, designer fees, sponsorship, and events. The current investors include designers and tech entrepreneurs. With the proceeds, Lone Design Club will grow store days by 250% and scale online by hiring more staff to fuel its growth.
days to go: Expired investment: £58,280
Brain Füd manufactures functional energy drinks made with natural caffeine, electrolytes, B-vitamins, and no artificial sweeteners. Since 2018, the company has been selling its drinks in universities, corporate offices, and online platforms such as Amazon and Ocado. The company's trial listing is in selected Sainsbury's stores nationwide. Brain Füd is in conversation with Amazon, Morrisons, and many more. With the proceeds, the company will directly appeal to its target audience and bag more distribution.
days to go: Expired investment: £110,307
Iknowa is a property improvement marketplace that connects and matches property owners with individuals or companies who provide property services. The company aims to be the go-to support platform for all building and renovation projects. Iknowa allows users to post jobs free of cost on its portal. The company has featured in publications like FinTech, Business Money and Showhouse. They have successfully raised over £250,000 to date. Iknowa will use 50% of the investment to maintain, improve & build new technology by the first quarter of 2021, 30% as operational costs, and 20% for sales and marketing.
days to go: Expired investment: £196,240
freemarketFX is an FCA authorised, innovative peer-to-peer currency exchange, focused on the high-value B2B commercial spot FX market.
days to go: Expired investment: £645,496
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph